Last reviewed · How we verify
Moisview Eye drop
Moisview is an eye drop formulation designed to treat dry eye disease by providing ocular surface lubrication and potentially reducing inflammation.
Moisview is an eye drop formulation designed to treat dry eye disease by providing ocular surface lubrication and potentially reducing inflammation. Used for Dry eye disease (keratoconjunctivitis sicca).
At a glance
| Generic name | Moisview Eye drop |
|---|---|
| Sponsor | Huons Co., Ltd. |
| Drug class | Ophthalmic lubricant / Dry eye disease therapeutic |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
Moisview eye drops work as a lubricating and protective agent for the ocular surface, helping to restore tear film stability and reduce symptoms associated with dry eye disease. The formulation is intended to provide sustained relief by maintaining moisture on the cornea and conjunctiva, potentially incorporating anti-inflammatory or mucoadhesive components typical of advanced dry eye therapeutics.
Approved indications
- Dry eye disease (keratoconjunctivitis sicca)
Common side effects
- Ocular irritation
- Transient blurred vision
- Eye discomfort
Key clinical trials
- HU007 in Patients with Dry Eye Syndrome (PHASE3)
- Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |